Remarks from Anthropic CEO @DarioAmodei on our initial public offering:
My co-founders and I started Anthropic because we believe that the most powerful technology of our time should be built for the benefit of humankind.
In the lab, I saw the vast thicket of complexity that scientists face when they’re trying to understand disease and develop new treatments.
So many of the scientific tools that can cut through that thicket—tools for gene editing, gene synthesis, controlling brain cells with light—started as pure ideas. In other words, they came from thinking. From intelligence.
Human intelligence has already made diseases like plague, smallpox, and polio history for most of the world. But progress on other diseases has been too slow for so many patients and their families.
Going from a great idea to a treatment can take decades: it took many years from the first discovery of a strange repeating pattern in DNA to the approval of the first treatment for a disease using CRISPR.
Nature is full of these patterns. But we’ve had too little intelligence to decipher most of them; too few scientists, with too little time. Now we can build that intelligence.
Whether it’s protein folding, drug design, cancer genetics, or clinical trial administration, scientists across many areas of biology and medicine are finding Claude can help them do their research in a fraction of the time it would’ve taken just a couple of years ago.
I believe sufficiently powerful AI, working in concert with humans, could compress a century of scientific and medical progress into a decade.
I don’t want to get ahead of myself. At this point all we have are early results. Experiments and clinical trials will still take time. And although they involve slow and ponderous processes, I believe those processes can be substantially accelerated by AI.
Daniela and I lost our father to a disease that, just a few years later, became curable. I started my career in biology, hoping to help future cures come sooner.